| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT00319033 |
| P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
| phase III clinical trial | Q42824827 | ||
| P17 | country | Canada | Q16 |
| United States of America | Q30 | ||
| Netherlands | Q55 | ||
| France | Q142 | ||
| Sweden | Q34 | ||
| Germany | Q183 | ||
| United Kingdom | Q145 | ||
| Italy | Q38 | ||
| Israel | Q801 | ||
| Switzerland | Q39 | ||
| P582 | end time | 2006-02-01 | |
| P2899 | minimum age | 18 | |
| P1132 | number of participants | 132 | |
| P6153 | research site | Georgetown University | Q333886 |
| University of Alabama | Q492318 | ||
| Virginia Mason Medical Center | Q7934403 | ||
| Gachon University Gil Hospital | Q12582491 | ||
| Sint Maartenskliniek (Woerden) | Q50038085 | ||
| Samsung Medical Center | Q624119 | ||
| University of Lausanne | Q658975 | ||
| Rabin Medical Center | Q2071553 | ||
| Thomas Jefferson University | Q2471216 | ||
| Denver Health Medical Center | Q3023367 | ||
| Cleveland Clinic | Q4117596 | ||
| Seoul National University Hospital | Q4403855 | ||
| Medical University of South Carolina | Q6806451 | ||
| P1813 | short name | BUILD 2 OL | |
| P580 | start time | 2004-07-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | Long-term Open-label Study in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis Who Completed the Protocol AC-052-330. |
Search more.